Asthma is a prevalent chronic condition that affects 235 million individuals worldwide, including children and adults. In the United States, an estimated 24.6 million people or 8.2% of the US population have asthma, and nearly half of these individuals experience at least 1 asthma exacerbation yearly.
In the past several years, there have been significant changes in the management of asthma in the United States, beginning with the publication of the updated Guidelines for the Diagnosis and Management of Asthma in the Expert Panel Report 3 of the National Asthma Education and Prevention Program (NAEPP) in 2007.
According to the Institute of Medicine, chronic pain affects an estimated 100 million individuals in the United States. Lower back pain (27%), severe headache or migraine (15%), and neck pain (15%) are among the most frequently reported pain conditions. The prevalence of pain is likely to increase in the future with the aging of the US population and with the increase in the number of injured military personnel.
Diabetes is a complex, chronic disease that is characterized by poor glycemic control and results from impaired insulin secretion, impaired insulin action, or both. Type 2 diabetes is the most common form of the disease and accounts for more than 90% of the estimated 29.1 million cases in the United States.
Asthma remains a significant public health issue, affecting approximately 25 million individuals in the United States alone. Despite the availability of evidence-based guidelines and newer, more effective therapies, adequate control of symptoms may be challenging, resulting in diminished quality of life, and in some cases, life-threatening exacerbations. Faculty Perspectives™ is a 4-part series addressing the latest issues in the care of patients with asthma. In this first issue, faculty experts discuss the prevalence, burden, epidemiology, and pathophysiology of the disease, the role of managed care pharmacy, and trends in management.
Optimal management of hematologic malignancies requires an early, accurate, complete, and clear diagnosis. Hematologic malignancies, however, are frequently misdiagnosed. Studies have demonstrated misdiagnosis in up to 27% of leukemia, 18% of lymphoma, and 75% of Burkitt lymphoma cases.
Page 2 of 4
Results 11 - 20 of 38
Results 11 - 20 of 38